Search
Search results
11 results found
Sydney Lauzier
New Publication by Dr. Campbell-Montalvo: Cultural Model Change in Kidney Disease Therapy
We are excited to announce a new publication by Dr. Rebecca Campbell-Montalvo, Director of the AQUASS Lab, in collaboration with Dr. Ashutosh Shukla (PI) and his research team, now available in Patient Education and Counseling: Understanding how patient education affects the process of treatment...
Kara Morhan
Understanding how patient education affects the process of treatment decision-making: Cultural model change in kidney disease therapy
Campbell-Montalvo, Rebecca, Darin Ftouni, Popy Shell, Shobha Subhash, Kailyn Pearce, and Ashutosh M. Shukla. 2025. “Understanding How Patient Education Affects the Process of Treatment Decision-Making: Cultural Model Change in Kidney Disease Therapy”. Patient Education and Counseling.
Johnathen Worth
Johnathen joined the Healthy Minds Lab in 2025 as a Clinical Research Associate. As a Veteran and a proud Citizen of the Muscogee Nation in Oklahoma, he brings a unique and deeply rooted perspective to his work, guided by a lifelong commitment to addressing health disparities and advancing public...
The role of matrix metalloproteinases in the modulation of aqueous humor in glaucoma patients.
Teodor, Cerbulescu, Barac Ileana Ramona, Boruga Ovidiu, Sălăvăţ Mădălina Casiana, Leuştean Laurenţiu, Duncă Ştefan Daciana, Calancea Andrei, and Barac Andreea Diana. 2025. “The Role of Matrix Metalloproteinases in the Modulation of Aqueous Humor in Glaucoma Patients.”. Romanian Journal of Ophthalmology 69 (2): 208-11.
Correction to: Prohibitin 1 inhibits cell proliferation and induces apoptosis via the p53-mediated mitochondrial pathway in vitro.
Shi, Juan-Juan, and Shuang-Suo Dang. 2025. “Correction To: Prohibitin 1 Inhibits Cell Proliferation and Induces Apoptosis via the P53-Mediated Mitochondrial Pathway in Vitro.”. World Journal of Gastrointestinal Oncology 17 (7): 110127.
Erratum: Correction of Authors and Supplementary Tables in the Article "Quality of Life in Women With Gestational Diabetes Mellitus and Treatment Satisfaction Upon Intermittently Scanned Continuous Glucose Monitoring".
Moon, Joon Ho, Hyeon Ji Kim, Jee Yoon Park, Kyung Joon Oh, Sung Hee Choi, and Hak Chul Jang. 2025. “Erratum: Correction of Authors and Supplementary Tables in the Article ‘Quality of Life in Women With Gestational Diabetes Mellitus and Treatment Satisfaction Upon Intermittently Scanned Continuous Glucose Monitoring’.”. Journal of Korean Medical Science 40 (28): e222.
CORRIGENDUM Bergaptol Ameliorates Insulin Sensitivity in Gestational Diabetes Mellitus by Inhibiting the Inflammatory Pathway in Streptozotocin-Induced Diabetic Rats.
Li, Q, J Chen, X Wang, L Zhuang, Z Yu, and D Yang. 2025. “CORRIGENDUM Bergaptol Ameliorates Insulin Sensitivity in Gestational Diabetes Mellitus by Inhibiting the Inflammatory Pathway in Streptozotocin-Induced Diabetic Rats.”. Physiological Research 74 (3): 537.